Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,830.00
-100.00 (-1.69%)
At close: Apr 2, 2026

Dongwha Pharm.Co.,Ltd Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
13,30525,65672,31734,34760,480
Short-Term Investments
11,0699,3317,26447,82054,800
Trading Asset Securities
-8,5099,24925,5276,230
Cash & Short-Term Investments
24,37443,49788,830107,695121,510
Cash Growth
-43.96%-51.03%-17.52%-11.37%0.98%
Accounts Receivable
83,01078,53564,74561,19456,291
Other Receivables
7,98921,9799,6225,4914,803
Receivables
90,999100,51474,36866,79561,093
Inventory
97,86789,32970,69746,78436,244
Prepaid Expenses
2,0502,4741,912843.38403.11
Other Current Assets
2,3251,9921,8935,411948.43
Total Current Assets
217,615237,806237,700227,527220,199
Property, Plant & Equipment
210,056219,546188,330151,153142,851
Long-Term Investments
64,12565,94272,64754,84750,616
Goodwill
24,93124,93124,9314,5564,556
Other Intangible Assets
57,16858,75425,09511,14713,582
Long-Term Deferred Tax Assets
11,1408,6236,2426,4006,194
Other Long-Term Assets
57,1334,0343,5755,5079,807
Total Assets
642,168619,635558,520461,136447,804
Accounts Payable
42,70938,86531,41222,23217,119
Accrued Expenses
16,71213,81813,60112,03210,445
Short-Term Debt
92,66531,33014,6702,5004,500
Current Portion of Leases
4,2145,8644,5472,1201,918
Current Income Taxes Payable
3,1644,1602,2242,9324,481
Current Unearned Revenue
--4.67--
Other Current Liabilities
43,36238,82038,52032,59226,843
Total Current Liabilities
202,826132,857104,98074,40865,307
Long-Term Debt
14,34944,50016,128477.133,460
Long-Term Leases
11,97615,29511,7561,5671,596
Long-Term Unearned Revenue
---22.8740.47
Pension & Post-Retirement Benefits
1,1936,1074,11373.1410,519
Long-Term Deferred Tax Liabilities
3,5944,1304,5922,0962,703
Other Long-Term Liabilities
6,79113,91613,0142,6642,892
Total Liabilities
240,728216,805154,58281,30986,517
Common Stock
27,93127,93127,93127,93127,931
Additional Paid-In Capital
18,52017,75717,75727,54527,545
Retained Earnings
300,355292,330292,251274,356252,712
Treasury Stock
-1,663-1,663-1,663-1,965-1,965
Comprehensive Income & Other
34,38337,01635,50336,53440,712
Total Common Equity
379,527373,371371,780364,400346,935
Minority Interest
21,91328,30431,00414,27313,198
Shareholders' Equity
401,440402,829403,938379,828361,288
Total Liabilities & Equity
642,168619,635558,520461,136447,804
Total Debt
123,20496,99047,1006,66411,474
Net Cash (Debt)
-98,830-53,49341,730101,031110,036
Net Cash Growth
---58.70%-8.18%5.15%
Net Cash Per Share
-3561.31-1932.701507.273650.063981.90
Filing Date Shares Outstanding
27.8527.7227.7227.6827.68
Total Common Shares Outstanding
27.8527.7227.7227.6827.68
Working Capital
14,789104,950132,721153,119154,892
Book Value Per Share
13627.4813470.3713412.9613165.1712534.17
Tangible Book Value
297,428289,686321,754348,698328,797
Tangible Book Value Per Share
10679.5910451.2311608.1512597.8711878.87
Land
44,63560,65060,72058,69159,118
Buildings
173,337122,036116,422110,623111,571
Machinery
124,623116,010113,50498,25793,686
Construction In Progress
9,05562,49533,90623,89613,628
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.